Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Current Assets: 2018-2025

Historic Current Assets for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to $154.1 million.

  • Verastem's Current Assets rose 27.68% to $154.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $154.1 million, marking a year-over-year increase of 27.68%. This contributed to the annual value of $95.0 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Verastem's Current Assets stood at $154.1 million, which was down 11.60% from $174.3 million recorded in Q2 2025.
  • Over the past 5 years, Verastem's Current Assets peaked at $190.0 million during Q2 2023, and registered a low of $92.9 million during Q4 2022.
  • Moreover, its 3-year median value for Current Assets was $122.7 million (2024), whereas its average is $136.9 million.
  • In the last 5 years, Verastem's Current Assets skyrocketed by 94.09% in 2023 and then crashed by 47.54% in 2024.
  • Quarterly analysis of 5 years shows Verastem's Current Assets stood at $105.7 million in 2021, then fell by 12.17% to $92.9 million in 2022, then surged by 60.43% to $174.5 million in 2023, then crashed by 30.85% to $95.0 million in 2024, then rose by 27.68% to $154.1 million in 2025.
  • Its Current Assets stands at $154.1 million for Q3 2025, versus $174.3 million for Q2 2025 and $124.7 million for Q1 2025.